Journal article
Effects of administration of tylosin on the duration of protective immunity induced by the novel Mycoplasma gallisepticum vaccine strain, Vaxsafe MG ts-304, in chickens
A Kanci Condello, CJ Morrow, SN Kulappu Arachchige, PK Shil, GJ Underwood, DM Andrews, OS Omotainse, AH Noormohammadi, PF Markham, NK Wawegama, GF Browning
Veterinary Microbiology | Published : 2023
Abstract
Prophylactic use of antimicrobials after administration of live vaccines is a common practice in the poultry industry, but the impact of this on the efficacy and duration of protection induced by the vaccines is unknown. The effect of treatment with tylosin on the efficacy of vaccination with the live attenuated M. gallisepticum strain, Vaxsafe MG ts-304, was examined. This vaccine has previously been shown to provide protection for at least 57 weeks. Ten-week-old specific-pathogen-free chickens were vaccinated with Vaxsafe MG ts-304 and then treated with tylosin at a therapeutic dose in drinking water from 6 weeks after vaccination. Tylosin was withdrawn 5 days before challenge with M. gall..
View full abstractGrants
Awarded by Australian Research Council
Funding Acknowledgements
The authors gratefully acknowledge the assistance of June Daly and Angela Chircop for care of the animals, Denise O'Rourke and Ling Zhu for the serological analyses, and Faye Docherty and Paul John Benham for assistance with histopathological processing. The investigators would also like to acknowledge the assistance of staff of Bioproperties Pty. Ltd. - Petrina Young, Fabian Carter, Hilda Joubert, Julie Brogestam and Gamini Jayawardane. This project was supported by an Australian Research Council Linkage Project Grant, LP160101105